Permanent Capital Management LP Invests $668,000 in Select Medical Holdings Corporation $SEM

Permanent Capital Management LP purchased a new position in Select Medical Holdings Corporation (NYSE:SEMFree Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 45,000 shares of the health services provider’s stock, valued at approximately $668,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Quantbot Technologies LP purchased a new position in Select Medical in the third quarter worth about $27,000. MAI Capital Management grew its holdings in shares of Select Medical by 48,000.0% during the second quarter. MAI Capital Management now owns 2,405 shares of the health services provider’s stock valued at $37,000 after buying an additional 2,400 shares during the last quarter. Cornerstone Planning Group LLC increased its position in shares of Select Medical by 6,868.4% during the third quarter. Cornerstone Planning Group LLC now owns 3,972 shares of the health services provider’s stock valued at $51,000 after acquiring an additional 3,915 shares in the last quarter. GAMMA Investing LLC raised its holdings in Select Medical by 147.9% in the 4th quarter. GAMMA Investing LLC now owns 4,713 shares of the health services provider’s stock worth $70,000 after acquiring an additional 2,812 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB lifted its position in Select Medical by 20.9% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock valued at $74,000 after acquiring an additional 999 shares in the last quarter. 89.48% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have commented on SEM shares. Royal Bank Of Canada reissued a “sector perform” rating and issued a $16.50 target price (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Wall Street Zen lowered Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, March 9th. Zacks Research cut shares of Select Medical from a “hold” rating to a “strong sell” rating in a research note on Thursday, February 26th. Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. Finally, Weiss Ratings upgraded shares of Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, February 20th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $15.63.

Check Out Our Latest Stock Report on Select Medical

Select Medical Price Performance

Shares of Select Medical stock opened at $16.27 on Friday. The stock has a market cap of $2.02 billion, a P/E ratio of 14.14, a P/E/G ratio of 0.93 and a beta of 1.22. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.04 and a current ratio of 1.04. The stock’s fifty day moving average is $15.63 and its 200 day moving average is $14.51. Select Medical Holdings Corporation has a one year low of $11.65 and a one year high of $18.60.

Select Medical (NYSE:SEMGet Free Report) last released its quarterly earnings results on Thursday, February 19th. The health services provider reported $0.16 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.07). Select Medical had a net margin of 2.68% and a return on equity of 7.26%. The company had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same period in the prior year, the firm posted $0.18 EPS. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Sell-side analysts anticipate that Select Medical Holdings Corporation will post 1.17 earnings per share for the current year.

Select Medical Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, March 12th. Investors of record on Monday, March 2nd were issued a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend was Monday, March 2nd. Select Medical’s dividend payout ratio is currently 21.74%.

Select Medical declared that its board has authorized a share buyback program on Thursday, February 19th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the health services provider to repurchase up to 49.5% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board of directors believes its stock is undervalued.

Select Medical Profile

(Free Report)

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.

Further Reading

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.